KILITCH evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-20T02:28:18.669029+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 2354749000.0
- net_income
- 301664000.0
- operating_cash_flow
- 189431000.0
- free_cash_flow
- -805643000.0
- total_assets
- 4577492000.0
- total_liabilities
- 1808821000.0
- total_equity
- 2796533000.0
- cash
- 167760000.0
- total_debt
- 887090000.0
- revenue_growth
- 0.18735720570698144
- earnings_growth
- 0.12980232653947854
- net_margin
- 0.12810877082865307
- roe
- 0.107870709911165
- debt_to_equity
- 0.31721063187883
- cash_conversion
- 0.6279536172695449
- free_cash_flow_margin
- -0.34213540381586316
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-cf966e29f2525ea22c1380806c3a0750f7a350c31272fdb4576dd19213a890b3
- Policy
- stock-decisions-v1
- Evidence bundle hash
- f5301d57226a760ed0b81587f06470d8fdd2942fda6160b8610c24bab5ef3fc3
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 26657c08b1998d32355d1b4782af9ad3d7813298954d9dbc2ebfe2c3c34cb9a0
- daily-price: b0dcc54d3492d857ae57e5d103cce63d001f88fe2db7420a65bd64bb302eb0af
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 218.51.
- The trailing 5-session price return was 0.59%.
- The trailing 20-session price return was 27.51%.
- The trailing 60-session price return was 19.33%.
- The trailing 250-session price return was 28.21%.
- Average cached traded value over twenty sessions was INR 5,711,602.
- The closing price was -2.57% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-20T02:28:18.669029+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.18735720570698144.
- The cached financial metric net margin is 0.12810877082865307.
- The cached financial metric roe is 0.107870709911165.
- The cached financial metric debt to equity is 0.31721063187883.
- The cached financial metric cash conversion is 0.6279536172695449.
- The cached financial metric free cash flow margin is -0.34213540381586316.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.